Health Care: Drugs

Synthetic Biologics Inc (SYN: AMEX)

$2.85 0.06 | 2.15%
06/30/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 0.00 0.00 0.00 0.00
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 0.00 0.00 0.00
Selling, General, and Administrative Expenses 6.01M 5.83M 5.01M 2.59M
Research & Development 14.49M 6.51M 12.29M 3.34M
Operating Income before D & A (EBITDA) -20.50M -12.34M -17.30M -5.93M
Depreciation & Amortization 20.00K 43.00K 63.00K 201.00K
Interest Income 3.00K 33.00K 33.00K 14.00K
Other Income - Net 715.00K -12.00K -18.00K -1.71M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -19.80M -12.36M -17.35M -7.83M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -19.80M -12.36M -17.35M -7.83M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 -1.00K 0.00 0.00
Net Income From Continuing Operations -19.78M -12.32M -17.28M -7.63M
Net Income From Discontinued Operations 0.00 0.00 216.00K -523.00K
Net Income From Total Operations -19.78M -12.32M -17.07M -8.15M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -19.78M -12.32M -17.07M -8.15M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-19.78M -12.32M -17.28M -7.63M
Preferred Dividends
Net Income Available To Common -19.78M -12.32M -17.28M -7.63M
Basic EPS from Continuing Ops. -0.32 -0.27 -0.50 -0.27
Basic EPS from Discontinued Ops. 0.00 0.00 0.01 -0.02
Basic EPS from Total Operations -0.32 -0.27 -0.49 -0.29
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.32 -0.27 -0.49 -0.29
Basic Normalized Net Income/Share -0.32 -0.27 -0.50 -0.27
EPS fr Continuing Ops. -0.32 -0.27 -0.50 -0.27
EPS fr Discontinued Ops 0.00 0.00 0.01 -0.02
EPS fr Total Ops. -0.32 -0.27 -0.49 -0.29
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.32 -0.27 -0.49 -0.29
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.32 -0.27 -0.50 -0.27
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with SYN

Latest SYN Headlines from TheStreet

More Financial News for SYN

Press Releases for SYN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter